Owens & Minor’s (OMI) “Hold” Rating Reaffirmed at Robert W. Baird

Owens & Minor, Inc. (NYSE:OMI)‘s stock had its “hold” rating restated by research analysts at Robert W. Baird in a research report issued to clients and investors on Thursday. They currently have a $28.00 price target on the stock. Robert W. Baird’s price objective would indicate a potential downside of 0.32% from the stock’s previous close.

A number of other analysts have also recently weighed in on OMI. BidaskClub cut shares of Owens & Minor from a “hold” rating to a “sell” rating in a research report on Tuesday, June 20th. Zacks Investment Research raised shares of Owens & Minor from a “sell” rating to a “hold” rating in a research report on Wednesday, July 5th. Jefferies Group LLC reaffirmed a “hold” rating and set a $36.00 price target on shares of Owens & Minor in a research report on Friday, July 7th. Finally, UBS AG reaffirmed a “sell” rating and set a $29.50 price target (down from $30.50) on shares of Owens & Minor in a research report on Thursday, August 3rd. Four equities research analysts have rated the stock with a sell rating and two have issued a hold rating to the company’s stock. The stock presently has a consensus rating of “Sell” and a consensus target price of $31.10.

Owens & Minor (NYSE:OMI) traded up 0.14% on Thursday, hitting $28.13. The stock had a trading volume of 364,010 shares. The company’s 50-day moving average price is $28.48 and its 200 day moving average price is $31.17. Owens & Minor has a one year low of $26.91 and a one year high of $37.02. The firm has a market cap of $1.72 billion, a price-to-earnings ratio of 17.89 and a beta of 1.03.

Owens & Minor (NYSE:OMI) last announced its quarterly earnings results on Tuesday, August 1st. The company reported $0.43 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.43. Owens & Minor had a net margin of 1.02% and a return on equity of 11.64%. The firm had revenue of $2.27 billion during the quarter, compared to analysts’ expectations of $2.38 billion. During the same period in the prior year, the company earned $0.52 EPS. The firm’s revenue was down 8.8% on a year-over-year basis. Analysts expect that Owens & Minor will post $1.92 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: This news story was posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright laws. The correct version of this news story can be read at https://www.com-unik.info/2017/10/12/owens-minors-omi-hold-rating-reaffirmed-at-robert-w-baird.html.

Large investors have recently bought and sold shares of the business. Flinton Capital Management LLC boosted its position in Owens & Minor by 62.7% in the 2nd quarter. Flinton Capital Management LLC now owns 3,904 shares of the company’s stock valued at $126,000 after buying an additional 1,504 shares during the last quarter. Creative Planning boosted its position in Owens & Minor by 2.9% in the 2nd quarter. Creative Planning now owns 4,021 shares of the company’s stock valued at $129,000 after buying an additional 113 shares during the last quarter. LS Investment Advisors LLC boosted its position in Owens & Minor by 17.1% in the 2nd quarter. LS Investment Advisors LLC now owns 4,987 shares of the company’s stock valued at $161,000 after buying an additional 727 shares during the last quarter. Legg Mason Asset Management Japan Co. Ltd. purchased a new position in Owens & Minor in the 2nd quarter valued at about $171,000. Finally, North Star Investment Management Corp. boosted its position in Owens & Minor by 121.0% in the 2nd quarter. North Star Investment Management Corp. now owns 5,667 shares of the company’s stock valued at $182,000 after buying an additional 3,103 shares during the last quarter. 97.77% of the stock is owned by institutional investors.

About Owens & Minor

Owens & Minor, Inc is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company’s segments include Domestic, International and Clinical & Procedural Solutions (CPS).

What are top analysts saying about Owens & Minor Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Owens & Minor Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit